These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 32708048)
1. Marine Actinomycetes-Derived Secondary Metabolites Overcome TRAIL-Resistance via the Intrinsic Pathway through Downregulation of Survivin and XIAP. Elmallah MIY; Cogo S; Constantinescu AA; Elifio-Esposito S; Abdelfattah MS; Micheau O Cells; 2020 Jul; 9(8):. PubMed ID: 32708048 [TBL] [Abstract][Full Text] [Related]
2. Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway. Premkumar DR; Jane EP; Foster KA; Pollack IF J Pharmacol Exp Ther; 2013 Aug; 346(2):201-10. PubMed ID: 23740602 [TBL] [Abstract][Full Text] [Related]
3. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells. Büneker CK; Yu R; Deedigan L; Mohr A; Zwacka RM Cancer Lett; 2012 Mar; 316(2):168-77. PubMed ID: 22104728 [TBL] [Abstract][Full Text] [Related]
4. Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode. Gillissen B; Richter A; Richter A; Overkamp T; Essmann F; Hemmati PG; Preissner R; Belka C; Daniel PT Cell Death Dis; 2013 May; 4(5):e643. PubMed ID: 23703388 [TBL] [Abstract][Full Text] [Related]
5. Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP. Kim EH; Kim SU; Shin DY; Choi KS Oncogene; 2004 Jan; 23(2):446-56. PubMed ID: 14724573 [TBL] [Abstract][Full Text] [Related]
6. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo. Mao HL; Pang Y; Zhang X; Yang F; Zheng J; Wang Y; Liu P Oncol Rep; 2013 Feb; 29(2):515-22. PubMed ID: 23151974 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines. Van Geelen CM; Pennarun B; Ek WB; Le PT; Spierings DC; De Vries EG; De Jong S Int J Oncol; 2010 Oct; 37(4):1031-41. PubMed ID: 20811726 [TBL] [Abstract][Full Text] [Related]
8. XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis. Ehrenschwender M; Bittner S; Seibold K; Wajant H Cell Death Dis; 2014 Dec; 5(12):e1570. PubMed ID: 25501831 [TBL] [Abstract][Full Text] [Related]
9. Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregulating the expression of antiapoptotic molecules. Taniguchi H; Horinaka M; Yoshida T; Yano K; Goda AE; Yasuda S; Wakada M; Sakai T Mol Cancer Ther; 2012 Oct; 11(10):2294-300. PubMed ID: 22784708 [TBL] [Abstract][Full Text] [Related]
10. Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps. Danish L; Imig D; Allgöwer F; Scheurich P; Pollak N PLoS One; 2018; 13(6):e0198203. PubMed ID: 29927992 [TBL] [Abstract][Full Text] [Related]
11. Co-treatment of birinapant with TRAIL synergistically induces apoptosis by downregulating cFLIP(L) in MDA-MB-453 cell lines. Park EJ; Kim HD; Choi EK; Hoe KL; Kim DU Biochem Biophys Res Commun; 2020 Dec; 533(3):289-295. PubMed ID: 32958259 [TBL] [Abstract][Full Text] [Related]
12. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells. Kauntz H; Bousserouel S; Gossé F; Raul F Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452 [TBL] [Abstract][Full Text] [Related]
13. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation. Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934 [TBL] [Abstract][Full Text] [Related]
14. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma. Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353 [TBL] [Abstract][Full Text] [Related]
15. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Bockbrader KM; Tan M; Sun Y Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155 [TBL] [Abstract][Full Text] [Related]
16. The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia. Saraei R; Soleimani M; Movassaghpour Akbari AA; Farshdousti Hagh M; Hassanzadeh A; Solali S Biomed Pharmacother; 2018 Nov; 107():1010-1019. PubMed ID: 30257312 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058 [TBL] [Abstract][Full Text] [Related]
18. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation. Kim JY; Kim EH; Kim SU; Kwon TK; Choi KS Carcinogenesis; 2010 Mar; 31(3):367-75. PubMed ID: 19939880 [TBL] [Abstract][Full Text] [Related]
19. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells. Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160 [TBL] [Abstract][Full Text] [Related]
20. Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappaB-mediated downregulation of xIAP. Thayaparasingham B; Kunz A; Peters N; Kulms D Oncogene; 2009 Jan; 28(3):345-62. PubMed ID: 18978816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]